NIVIPI-Brain: Phase 2 Study of Nivolumab plus Ipilimumab Combined With Chemotherapy in NSCLC With Synchronous Brain Metastases - Nadal, E; Cantero, A; Paz-Ares, L; Ortega, A L; Barba, A; Iranzo, P; Domine, M; Garcia, J; Blasco, A; Campelo, R Garcia; Rodriguez-Abreu, D; Castro, R Lopez; et al. (Journal of Thoracic Oncology, 2025)